ORDER A TEST Log In Contact Us

TEMPUS CLINICAL RESEARCH

Accelerate clinical trial enrollment with our oncology clinical trial network, AI-powered patient identification, and rapid start up timelines
Schedule a demo

Accelerate enrollment in your clinical trials

  • Increase site efficiency and enrollment to improve your trial program’s performance
    Increase site efficiency and enrollment to improve your trial program’s performance

    TriHealth achieved 64% annual increase in patients enrolled in clinical trials, with Tempus TIME driving 95% of growth.

    Read the case study
  • Find patients with rare mutations for your targeted therapy trials
    Find patients with rare mutations for your targeted therapy trials

    Aadi Bioscience accelerated enrollment for its PRECISION 1 trial by using the TIME program to identify patients with rare TSC1 or TSC2 mutations.

    Read the case study
  • Accelerate trial timelines from activation to enrollment.
    Accelerate trial timelines from activation to enrollment.

    With the TIME program, Sermonix shortened its ELAINE-2 trial enrollment by 10 months, achieving first patient 115 days faster than at traditional sites.

    Read the case study

one of THe Largest oncology networks in the nation

  • ~100

    sites representing 800+ clinical locations

  • 5M+

    cancer patients covered in our trial network

  • 1.5k+

    clinical trials have been active

  • ~10

    business days for Just-in-Time trial activation

  • ~90%

    community sites

image description

TEMPUS TIME NETWORK

Tempus Time powers smart sites, creating a network poised to streamline clinical development

Sites can open upfront or after they have identified a patient in our Just In Time model which enables activation just a few days before the study opens at your site.

Our vast TIME network of academic medical centers and community-based practices continues to grow, enabling trial access for all patients — regardless of location.

accelerated site activation

Activate sites quickly, before or after patient identification

The TIME network complements your traditional trial sites by bringing your study to patients faster, in locations where they already receive care. We do this through rapid site activation, standardized study start-up documentation, and site engagement initiatives.

  • Expedited activation: Through a series of streamlined activities and agreements, sites may be activated in ~30 business days prior to identifying the first eligible patient for your trial.
  • Just-in-Time activation: Utilizing the same operational efficiencies, TIME can help you activate new sites for your trial in ~10 business days for an identified eligible patient.

Tempus Link

Identify potential trial patients, streamline workflows, and accelerate enrollment on one AI-powered platform. Our AI analyzes structured and unstructured clinical data to improve patient identification for trials.
Learn more
  • Clinical trial selection tooling

    Use patient population data to asses your site’s potential for successful trial enrollment.

  • Pre-screen patients

    Quickly pre-screen lists of patients identified as potentially eligible for a specific trial.

  • Trial matching

    Nurses review AI-identified matches to confirm eligibility before sharing with TIME network sites. Matches are prioritized by factors like upcoming clinic visits and treatment decisions to accelerate enrollment.

image description

Support for your US-based trial enrollment plan

85% of patients with cancer are treated in community centers.1 Tempus’ TIME Network includes hundreds of community site locations across the U.S., supporting efforts to enroll US-based patients and diversity plans due to the representative patient population.

TIME also supports your ability to deploy a trial within days at any location within the community via Just In Time.

  1. National Cancer Institute. (2017, September 21). Bringing Research to the Community to Reduce Cancer Disparities. https://www.cancer.gov/research/areas/disparities/chanita-hughes-halbert-clinical-trials-community-access
  2. TIME county ethnicity is calculated using weighted average of county population using the ethnicity breakdown of each county of active TIME sites,10/2024. Census data from www.data.census.gov Accessed 10/2024
image description

Featured News and Events

view all news
  • UPCOMING WEBINAR:

    Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model

    Tempus’ Just-in-TIME model, when used with a traditional approach, can improve patient enrollment in biomarker-driven clinical studies.

    Learn more
  • UPCOMING WEBINAR:

    Oral presentation at ASCO: A technology-enabled clinical trial program’s impact on patient screening and trial enrollment in 2024.

    Tempus’ technology-enabled clinical trial program, utilizing an algorithmic screening platform, was shown to improve patient access and trial enrollment success by centralizing patient data and rapidly matching them to suitable trials.

    Learn more
  • UPCOMING WEBINAR:

    Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment

    The TIME Precision Network is a newly-formed group of investigators across TIME’s provider site network dedicated to supporting Phase I trials.

    Learn more
  • UPCOMING WEBINAR:

    Tempus Announces Partnership with OneOncology

    Tempus is collaborating with OneOncology, the fastest-growing national platform for independent oncology practices, to broaden patient access to cutting-edge clinical trials.

    Learn more
  • UPCOMING WEBINAR:

    Optimizing Clinical Trial Subject Selection: Insights from Exigent Research Network and the Tempus AI TIME Program Collaboration

    The Exigent Research Network comprises independent community oncology practices engaged in clinical research. This publication describes the Exigent and TIME Program collaboration during a 2-year period and its impact on screening, matching, and enrollment into clinical trials.

    Learn more
  • UPCOMING WEBINAR:

    TriHealth Cancer Institute’s collaboration with the Tempus AI TIME program impact on clinical trial operations and enrollment

    TriHealth Cancer Institute has the largest personalized medicine program serving Cincinnati. TriHealth’s EMR integration with Tempus AI TIME allows for patient screening using an AI powered software TApp that matches to a broad clinical trial portfolio.

    Learn more

Trusted by hundreds of biopharma to power drug development

EXPLORE LIFE SCIENCES SOLUTIONS
EXPLORE LIFE SCIENCES SOLUTIONS

The information on this page is intended for life sciences companies and focuses on research and development applications.